MedPath

Evaluation of the effects of venlafaxine and Acceptance and Commitment Therapy (ACT) enriched with Compassion Focus Therapy (CFT) on depression, stress, and anxiety

Phase 3
Recruiting
Conditions
F06.31
in addict patients undergoing Methadone Maintenance Therapy.
Mood disorder due to known physiological condition with depressive features
Registration Number
IRCT20191106045356N3
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
60
Inclusion Criteria

Duration of methadon use for at least the 6 months
The age range of 20_45 years

Exclusion Criteria

Existence of severe mental disorder such as psychosis
Existence of instant psychosis due to psychotropic consumption.
Simultaneous use of NA and similar classes.
Having chronic physical illnesses that affect mood and emotions.
Use of opiates and morphine
Not doing homework at home
Failure to complete the questionnaire in pre-test and post-test

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath